Fennec Pharmaceuticals Statistics Share Statistics Fennec Pharmaceuticals has 27.62M
shares outstanding. The number of shares has increased by 0.95%
in one year.
Shares Outstanding 27.62M Shares Change (YoY) 0.95% Shares Change (QoQ) 0.09% Owned by Institutions (%) 48.55% Shares Floating 23.03M Failed to Deliver (FTD) Shares 8,491 FTD / Avg. Volume 10.47%
Short Selling Information The latest short interest is 1.3M, so 4.72% of the outstanding
shares have been sold short.
Short Interest 1.3M Short % of Shares Out 4.72% Short % of Float 6.83% Short Ratio (days to cover) 18.76
Valuation Ratios The PE ratio is -395.64 and the forward
PE ratio is 9.39.
Fennec Pharmaceuticals's PEG ratio is
4.06.
PE Ratio -395.64 Forward PE 9.39 PS Ratio 3.63 Forward PS 3.1 PB Ratio -31.33 P/FCF Ratio 6.39 PEG Ratio 4.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Fennec Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.38,
with a Debt / Equity ratio of -3.51.
Current Ratio 6.38 Quick Ratio 6.22 Debt / Equity -3.51 Debt / EBITDA 5.37 Debt / FCF 0.72 Interest Coverage 0.63
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.49M Profits Per Employee $-13.63K Employee Count 32 Asset Turnover 1.06 Inventory Turnover 3
Taxes Income Tax 365K Effective Tax Rate -514.08%
Stock Price Statistics The stock price has increased by 31.84% in the
last 52 weeks. The beta is 0.4, so Fennec Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.4 52-Week Price Change 31.84% 50-Day Moving Average 8.34 200-Day Moving Average 6.56 Relative Strength Index (RSI) 49.51 Average Volume (20 Days) 81,137
Income Statement In the last 12 months, Fennec Pharmaceuticals had revenue of 47.54M
and earned -436K
in profits. Earnings per share was -0.02.
Revenue 47.54M Gross Profit 44.35M Operating Income 2.57M Net Income -436K EBITDA 3.6M EBIT 2.57M Earnings Per Share (EPS) -0.02
Full Income Statement Balance Sheet The company has 26.63M in cash and 19.34M in
debt, giving a net cash position of 7.29M.
Cash & Cash Equivalents 26.63M Total Debt 19.34M Net Cash 7.29M Retained Earnings -219.68M Total Assets 46.4M Working Capital 34.6M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 26.98M
and capital expenditures 0, giving a free cash flow of 26.98M.
Operating Cash Flow 26.98M Capital Expenditures n/a Free Cash Flow 26.98M FCF Per Share 0.99
Full Cash Flow Statement Margins Gross margin is 93.3%, with operating and profit margins of 5.4% and -0.92%.
Gross Margin 93.3% Operating Margin 5.4% Pretax Margin -0.15% Profit Margin -0.92% EBITDA Margin 7.57% EBIT Margin 5.4% FCF Margin 56.75%
Dividends & Yields FENC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for FENC is $13,
which is 57.8% higher than the current price. The consensus rating is "Strong Buy".
Price Target $13 Price Target Difference 57.8% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 9, 2014. It was a
backward
split with a ratio of 1:3.
Last Split Date Sep 9, 2014 Split Type backward Split Ratio 1:3
Scores Altman Z-Score -2.8 Piotroski F-Score 1
